Sadlecki Pawel, Dejewska Katarzyna, Domieracka Patrycja, Walentowicz-Sadlecka Malgorzata
Faculty of Medicine, University of Science and Technology, Bydgoszcz, Poland.
Department of Obstetrics, Gynecology and Gynecologic Oncology, Regional Polyclinical Hospital, Grudziadz, Poland.
Open Med (Wars). 2025 Aug 19;20(1):20251267. doi: 10.1515/med-2025-1267. eCollection 2025.
Giant borderline ovarian tumours (GBOTs) are rare neoplasms that require meticulous management to prevent high-risk operative complications. The broader goal of this systematic review is to consolidate the existing knowledge on GBOTs by focusing on diagnostic approaches, differential diagnoses, and treatment strategies. Furthermore, the relationship between the clinical features of GBOTs and the types of diagnostic and therapeutic procedures implemented was determined.
The publications were analysed for the following data: histopathological type of GBOT; patient's age; dimensions, weight, and/or volume of the tumour; levels and types of tumour markers determined; types of imaging tests performed; type of treatment applied.
Twenty-one articles describing the clinical situation of 22 patients met the inclusion criteria for the systematic review. The mean age of the patients included in the analysis was 46.68 years (SD: 19.1 years); the youngest patient was 12, and the oldest was 76 years of age. In the analysed literature, patients most often (81.8%) had the mucinous type of GBOT. In the vast majority of cases (86.36%), based on the analysed literature, the surgical treatment method for the patients was laparotomy. In more than half of the patients (54.55%), the uterus was removed during surgical treatment. In the analysed literature, the hysterectomy procedure was not performed in patients under 40 years of age. Based on the analysed literature, it was found that if the CA 125 concentration in the blood serum of patients with mucosal tumours exceeded 40 U/mL, laparoscopy was not performed and the patients were treated using an open approach.
GBOTs are rare neoplasms that require meticulous management to prevent high-risk operative complications. Despite the diagnostic and therapeutic challenges posed by the large size and potential complications of these tumours, with proper medical care, patients can achieve successful outcomes and a good prognosis.
巨大卵巢交界性肿瘤(GBOTs)是罕见的肿瘤,需要精心管理以预防高风险手术并发症。本系统评价的更广泛目标是通过关注诊断方法、鉴别诊断和治疗策略来巩固关于GBOTs的现有知识。此外,还确定了GBOTs的临床特征与所实施的诊断和治疗程序类型之间的关系。
分析出版物中的以下数据:GBOT的组织病理学类型;患者年龄;肿瘤的尺寸、重量和/或体积;测定的肿瘤标志物水平和类型;进行的影像学检查类型;应用的治疗类型。
21篇描述22例患者临床情况的文章符合系统评价的纳入标准。分析中纳入患者的平均年龄为46.68岁(标准差:19.1岁);最年轻的患者为12岁,最年长的为76岁。在分析的文献中,患者最常(81.8%)患有黏液性GBOT。根据分析的文献,在绝大多数病例(86.36%)中,患者的手术治疗方法是剖腹手术。超过一半的患者(54.55%)在手术治疗期间切除了子宫。在分析的文献中,40岁以下患者未进行子宫切除术。根据分析的文献发现,如果黏膜肿瘤患者血清中的CA 125浓度超过40 U/mL,则不进行腹腔镜检查,患者采用开放手术方法治疗。
GBOTs是罕见的肿瘤,需要精心管理以预防高风险手术并发症。尽管这些肿瘤体积大且存在潜在并发症带来了诊断和治疗挑战,但通过适当的医疗护理,患者可以获得成功的结果和良好的预后。